Lv11
40 积分 2021-03-24 加入
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study
2分钟前
待确认
HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion
6分钟前
已完结
Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion
1个月前
已完结
A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease
1个月前
已完结
Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial
9个月前
已完结
A study on the efficacy and safety of anlotinib in patients with metastatic pheochromocytoma and paraganglioma
9个月前
已关闭
The preliminary efficacy and safety results of neoadjuvant phase 2 study of penpulimab combined with taxanes and carboplatin in triple-negative breast cancer (neoTAPPL)
9个月前
已关闭
Cancer incidence and mortality in China, 2022
10个月前
已完结
[Chinese expert consensus on multidisciplinary diagnosis and treatment of radiation rectal injury (2021 edition)]
1年前
已完结
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial
1年前
已完结
皖公网安备34019202002308
